201 related articles for article (PubMed ID: 26902939)
41. Improved patency and reduced intimal hyperplasia in PTFE grafts with luminal immobilized heparin compared with standard PTFE grafts at six months in a sheep model.
Pedersen G; Laxdal E; Ellensen V; Jonung T; Mattsson E
J Cardiovasc Surg (Torino); 2010 Jun; 51(3):443-8. PubMed ID: 20523297
[TBL] [Abstract][Full Text] [Related]
42. Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study.
Larena-Avellaneda A; Russmann S; Fein M; Debus ES
J Vasc Surg; 2009 Oct; 50(4):790-8. PubMed ID: 19660894
[TBL] [Abstract][Full Text] [Related]
43. [Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
Moroi K; Shiomi Y; Kumano H; Ishimura N; Nishiwada M
Masui; 1997 Aug; 46(8):1085-9. PubMed ID: 9283165
[TBL] [Abstract][Full Text] [Related]
44. PEPE II--a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency.
Hugl B; Nevelsteen A; Daenens K; Perez MA; Heider P; Railo M; Schelzig H; Gluecklich B; Balzer K; Vermassen F; De Smit P; Fraedrich G;
J Cardiovasc Surg (Torino); 2009 Apr; 50(2):195-203. PubMed ID: 19329916
[TBL] [Abstract][Full Text] [Related]
45. An infrequent complication of a not so infrequent disease. Hit by HIT.
Sandoval E; Ascaso M; Quintana E; Pereda D
Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):124-126. PubMed ID: 30011999
[TBL] [Abstract][Full Text] [Related]
46. Single-center experience in endovascular treatment for infrainguinal bypass obstructions.
Baumann F; Engelberger RP; Makaloski V; Do DD; Baumgartner I; Diehm N
J Vasc Interv Radiol; 2012 Aug; 23(8):1055-62. PubMed ID: 22840804
[TBL] [Abstract][Full Text] [Related]
47. A new management for limb graft occlusion after endovascular aneurysm repair adding a vollmar ring stripper: the unclogging technique.
Ronsivalle S; Faresin F; Franz F; Pedon L; Rettore C; Zonta L; Olivieri A
Ann Vasc Surg; 2013 Nov; 27(8):1216-22. PubMed ID: 24011815
[TBL] [Abstract][Full Text] [Related]
48. Retaining a nonfunctional synthetic arterial bypass graft as a tunnel for future bypass using a vein graft: technical note.
Durai R; Hoque H; Raudonaitis A
Ann Vasc Surg; 2010 Jan; 24(1):149-50. PubMed ID: 19619978
[TBL] [Abstract][Full Text] [Related]
49. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease.
Ricco JB; Probst H;
J Vasc Surg; 2008 Jan; 47(1):45-53; discussion 53-4. PubMed ID: 17997269
[TBL] [Abstract][Full Text] [Related]
50. Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair.
Kolluri R; Rocha-Singh K; Sarac T; Bartholomew JR
Vasc Endovascular Surg; 2009; 43(1):89-92. PubMed ID: 18799498
[TBL] [Abstract][Full Text] [Related]
51. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
52. Can a coated Dacron vascular graft maintain a heparin-induced thrombocytopenia type II?
Bürger T; Tautenhahn J; Böck M; Fahlke J; Halloul Z; Lippert H
Langenbecks Arch Surg; 2001 Jul; 386(4):267-71. PubMed ID: 11466568
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment of synthetic vascular grafts with heparin before implantation, a simple technique to reduce the risk of thrombosis.
Gerrah R; Sunstrom Pa-C RE; Hohimer AR
Vascular; 2015 Oct; 23(5):513-8. PubMed ID: 25406265
[TBL] [Abstract][Full Text] [Related]
54. Intravascular Ultrasound-Assisted Crosser System Through the Retrograde Approach to Treat a Trans-Atlantic Inter-Society Consensus D Lesion in the Superficial Femoral Artery After Graft Failure.
Matsumi J; Tobita K; Saito S
Ann Vasc Surg; 2016 Apr; 32():130.e13-9. PubMed ID: 26806241
[TBL] [Abstract][Full Text] [Related]
55. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial.
Eiberg JP; Røder O; Stahl-Madsen M; Eldrup N; Qvarfordt P; Laursen A; Greve M; Flörenes T; Nielsen OM; Seidelin C; Vestergaard-Andersen T; Schroeder TV
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):431-8. PubMed ID: 16807001
[TBL] [Abstract][Full Text] [Related]
56. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
LaMuraglia GM; Houbballah R; Laposata M
J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
[TBL] [Abstract][Full Text] [Related]
57. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
[TBL] [Abstract][Full Text] [Related]
58. Recurrent cystic adventitial disease of the iliofemoral artery.
Rehman S; Hancock L; Wolfe J
Ann Vasc Surg; 2010 May; 24(4):550.e1-3. PubMed ID: 20036507
[TBL] [Abstract][Full Text] [Related]
59. A Case of Posterior Circulation Ischemic Stroke Caused by Heparin-Induced Thrombocytopenia after Detaining Hepatic Arterial Infusion Catheter.
Hirashita K; Matsumoto A; Yabuno S; Kanda T; Yunoki M; Yoshino K
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e196-e200. PubMed ID: 29859863
[TBL] [Abstract][Full Text] [Related]
60. Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results.
Walluscheck KP; Bierkandt S; Brandt M; Cremer J
J Cardiovasc Surg (Torino); 2005 Aug; 46(4):425-30. PubMed ID: 16160689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
